BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28975431)

  • 1. Comparison of plasma/serum levels of procalcitonin between infection and febrile disease flare in patients with systemic lupus erythematosus: a meta-analysis.
    Liu LN; Wang P; Guan SY; Li XM; Li BZ; Leng RX; Pan HF
    Rheumatol Int; 2017 Dec; 37(12):1991-1998. PubMed ID: 28975431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review.
    Serio I; Arnaud L; Mathian A; Hausfater P; Amoura Z
    Clin Rheumatol; 2014 Sep; 33(9):1209-15. PubMed ID: 25064130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum procalcitonin and C-reactive protein levels as diagnostic markers for distinguishing bacterial infections from lupus flares in systemic lupus erythematosus: A systematic review and meta‑analysis.
    Chen Y; Shen J; Yang H; Xu S; Ma Y; Pan F
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108304. PubMed ID: 34731783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus.
    Lanoix JP; Bourgeois AM; Schmidt J; Desblache J; Salle V; Smail A; Mazière JC; Betsou F; Choukroun G; Duhaut P; Ducroix JP
    Lupus; 2011 Feb; 20(2):125-30. PubMed ID: 20937623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma/Serum Leptin Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis.
    Li HM; Zhang TP; Leng RX; Li XP; Li XM; Pan HF
    Arch Med Res; 2015 Oct; 46(7):551-6. PubMed ID: 26452329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus.
    Quintana G; Medina YF; Rojas C; Fernandez A; Restrepo JF; Rondon F; Iglesias A
    J Clin Rheumatol; 2008 Jun; 14(3):138-42. PubMed ID: 18525431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma/serum levels of prolactin in systemic lupus erythematosus: a systematic review and meta-analysis.
    Wang P; Lv TT; Guan SY; Li HM; Leng RX; Zou YF; Pan HF
    Postgrad Med; 2017 Jan; 129(1):126-132. PubMed ID: 27666289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum procalcitonin has negative predictive value for bacterial infection in active systemic lupus erythematosus.
    Bador KM; Intan S; Hussin S; Gafor AH
    Lupus; 2012 Oct; 21(11):1172-7. PubMed ID: 22652631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.
    Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N
    Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of serum procalcitonin and C-reactive protein for evaluating pulmonary bacterial infection in patients with lupus erythematosus.
    Gao J; Zhang L; Zhang X; Zhao SL; Liu SY; Xing LH
    J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):653-658. PubMed ID: 27752903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin and C-reactive protein as markers of infection in systemic lupus erythematosus: the controversy continues.
    El-Serougy E; Zayed HS; Ibrahim NM; Maged LA
    Lupus; 2019 Oct; 28(11):1329-1336. PubMed ID: 29779437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum presepsin, procalcitonin, copeptin, and high-sensitivity C-reactive protein for differentiating bacterial infection from disease activity in Egyptian patients with systemic lupus erythematosus.
    AlJarhi UM; Sadek KM; Darwish EM; Elmessiery RM; Salem K; Khalil SA; Seif El Nasr SM; Kamel MF; Hesham D; Fayed A
    Clin Rheumatol; 2021 May; 40(5):1861-1869. PubMed ID: 33111183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating flare and infection in febrile lupus patients: Derivation and validation of a calculator for resource constrained settings.
    Mehta P; Singh K; Anand S; Parikh A; Patnaik A; Chatterjee R; Lawrence A; Tripathy SR; Kavadichanda C; Rajasekhar L; Vs N; Das B; Amita A
    Lupus; 2022 Sep; 31(10):1254-1262. PubMed ID: 35786213
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of association between mean platelet volume and disease activity in systemic lupus erythematosus patients: a systematic review and meta-analysis.
    Zhao CN; Mao YM; Wang P; Guan SY; Sam NB; Li XM; Wang DG; Pan HF
    Rheumatol Int; 2018 Sep; 38(9):1635-1641. PubMed ID: 29845430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study.
    Torres-Ruiz J; Barrera-Vargas A; Ortiz-Hernández R; Alcocer-Varela J; Ponce-de-León A; Gómez-Martín D
    Lupus; 2018 Feb; 27(2):312-318. PubMed ID: 28699377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of MBL, PCT, CRP, neutrophil-lymphocyte ratio, and platelet lymphocyte ratio in differentiating infections from flares in lupus.
    Musunuri B; Tripathy R; Padhi S; Panda AK; Das BK
    Clin Rheumatol; 2022 Nov; 41(11):3337-3344. PubMed ID: 35835900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic values of C-reactive protein and procalcitonin in identifying systemic lupus erythematosus infection and disease activity.
    Wang J; Niu R; Jiang L; Wang Y; Shao X; Wu M; Ma Y
    Medicine (Baltimore); 2019 Aug; 98(33):e16798. PubMed ID: 31415387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum procalcitonin in systemic autoimmune diseases--where are we now?
    Buhaescu I; Yood RA; Izzedine H
    Semin Arthritis Rheum; 2010 Oct; 40(2):176-83. PubMed ID: 20132965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin.
    Kim HA; Jeon JY; An JM; Koh BR; Suh CH
    J Rheumatol; 2012 Apr; 39(4):728-34. PubMed ID: 22337236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil CD64 expression, procalcitonin and presepsin are useful to differentiate infections from flares in SLE patients with SIRS.
    Echeverri A; Naranjo-Escobar J; Posso-Osorio I; Aguirre-Valencia D; Zambrano D; Castaño GL; Martínez JD; Cañas CA; Tobón GJ
    Lupus; 2018 Jun; 27(7):1130-1139. PubMed ID: 29540108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.